Lv5
926 积分 2022-11-02 加入
In vivo chimeric antigen receptor (CAR)-T cell therapy
7天前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
14天前
已完结
LBA-11 First-in-Human Clinical Proof-of-Concept of IASO206, an Intravenously Administered In Vivo BCMA CAR-T Therapy for Patients With Relapsed/Refractory Multiple Myeloma
14天前
已关闭
Nonclinical Toxicology, Biodistribution, and Pharmacokinetics of UB-VV111, an In Vivo Anti-CD19 CAR T Cell Therapy
16天前
已完结
Phase 1 Study of Anito-cel, a d -Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
27天前
已完结
In vivo genome-wide CRISPR screens of human T cells in solid tumours
1个月前
已完结
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
1个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
7个月前
已完结
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
7个月前
已完结
Anti-BCMA CAR-T therapy in patients with progressive multiple sclerosis
7个月前
已完结
皖公网安备34019202002308
